Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-20

FDA Approved: OLANZAPINE — Supplemental Application (Dr. Reddy's Laboratories Ltd.)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories Ltd.'s supplemental application for olanzapine, enabling a generic olanzapine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)